SEMA6D and neoplasm: Compared with WT mice, Sema6d-KO mice showed significantly slower tumor growth (Figure 2B) and a significantly higher number of tumor-infiltrating CD8+ T cells and OVA-tetramer+CD8+ T cells (Figure 2C and Supplemental Figure 4).